Reduced erythrocyte CR1 levels in patients with pulmonary tuberculosis is an acquired phenomenon

Clinical Immunology

Volumn 128, Issue 1, 2008, Pages 109-115

  Senbagavalli, P ^a   Geetha, S T ^b   Karunakaran, K ^b   Banu Rekha, V V ^a   Venkatesan, P ^a   Ramanathan, V D ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b Corporation TB Clinic ^*  (India)

Author keywords

Circulating immune complexes; CR1 density polymorphism; Erythrocyte complement receptor 1 (E CR1); Indian subjects; Pulmonary tuberculosis

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL;

ADULT; ANTIGEN-ANTIBODY COMPLEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, COMPLEMENT 3B; TUBERCULOSIS, PULMONARY;

EID: 49949152534     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.02.012     Document Type: Article

References (33)

1. Bhatt K., and Salgame P. Host innate immune response to Mycobacterium tuberculosis. J. Clin. Immunol. 27 (2007) 347-362
2. Lyashchenko K., Colangeli R., Houde M., Al Jahdali H., Menzies D., and Gennaro M.L. Heterogeneous antibody responses in tuberculosis. Infect. Immun. 66 (1998) 3936-3940
3. Schoel B., Gulle H., and Kaufmann S.H. Heterogeneity of the repertoire of T cells of tuberculosis patients and healthy contacts to Mycobacterium tuberculosis antigens separated by high-resolution techniques. Infect. Immun. 60 (1992) 1717-1720
4. Ramanathan V.D., Parkash O., Ramu G., Parker D., Curtis J., Sengupta U., and Turk J.L. Isolation and analysis of circulating immune complexes in leprosy. Clin. Immunol. Immunopathol. 32 (1984) 261-268
5. Brostoff J., Lenzini L., Rottoli P., and Rottoli L. Immune complexes in the spectrum of tuberculosis. Tubercle 62 (1981) 169-173
6. Johnson N.M., McNicol M.W., Burton-Kee E.J., and Mowbray J.F. Circulating immune complexes in tuberculosis. Thorax 36 (1981) 610-617
7. Wemambu S.N., Turk J.L., Waters M.F., and Rees R.J. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet 2 (1969) 933-935
8. Cornacoff J.B., Hebert L.A., Smead W.L., VanAman M.E., Birmingham D.J., and Waxman F.J. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 71 (1983) 236-247
9. Birmingham D.J. Erythrocyte complement receptors. Crit. Rev. Immunol. 15 (1995) 133-154
10. Wilson J.G., Murphy E.E., Wong W.W., Klickstein L.B., Weis J.H., and Fearon D.T. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J. Exp. Med. 164 (1986) 50-59
11. Cornillet P., Philbert F., Kazatchkine M.D., and Cohen J.H. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J. Immunol. Methods 136 (1991) 193-197
12. Lach-Trifilieff E., Marfurt J., Schwarz S., Sadallah S., and Schifferli J.A. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients. J. Immunol. 162 (1999) 7549-7554
13. Katyal M., Tiwari S.C., Kumar A., Dinda A.K., Arora V., Kumar R., and Das N. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects. Mol. Immunol. 40 (2004) 1325-1332
14. Zorzetto M., Bombieri C., Ferrarotti I., Medaglia S., Agostini C., Tinelli C., Malerba G., Carrabino N., Beretta A., Casali L., Pozzi E., Pignatti P.F., Semenzato G., Cuccia M.C., and Luisetti M. Complement receptor 1 gene polymorphisms in sarcoidosis. Am. J. Respir. Cell Mol. Biol. 27 (2002) 17-23
15. Cohen J.H., Caudwell V., Levi-Strauss M., Bourgeois P., and Kazatchkine M.D. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis. Rheum. 32 (1989) 393-397
16. Panchamoorthy G., Tiwari S.C., and Srivastava L.M. Inherited structural and quantitative polymorphisms of C3b receptor (CR1) in normals and patients with glomerular diseases, Asian. Pacific. J. Allergy Immunol. 11 (1993) 123-129
17. Kumar A., Malaviya A.N., and Srivastava L.M. Lowered expression of C3b receptor (CR1) on erythrocytes of rheumatoid arthritis patients. Immunobiology. 191 (1994) 9-20
18. Samuel A.M., Ashtekar M.D., and Ganatra R.D. Significance of circulating immune complexes in pulmonary tuberculosis. Clin. Exp. Immunol. 58 (1984) 317-324
19. Thomsen B.S., Nielsen H., and Bendixen G. Erythrocyte CR1 determination using monoclonal antibody in a microtiter plate ELISA; receptors are not masked by immune complexes. Allergy 41 (1986) 479-486
20. Thomsen B.S., Nielsen H., and Bendixen G. A microtiter plate enzyme-linked immunosorbent assay for measuring C3b receptors on human erythrocytes. J. Immunol. Methods 81 (1985) 259-269
21. Naik S. Can we look forward to genetic tests for tuberculosis susceptibility and severity?. Indian J. Med. Res. 124 (2006) 379-382
22. Fitness J., Floyd S., Warndorff D.K., Sichali L., Malema S., Crampin A.C., Fine P.E., and Hill A.V. Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am. J. Trop. Med. Hyg. 71 (2004) 341-349
23. Katyal M., Sivasankar B., Ayub S., and Das N. Genetic and structural polymorphism of complement receptor 1 in normal Indian subjects. Immunol. Lett. 89 (2003) 93-98
24. Tausk F., Hoffmann T., Schreiber R., and Gigli I. Leprosy: altered complement receptors in disseminated disease. J. Invest. Dermatol. 85 (1985) 58s-61s
25. Ross G.D., Yount W.J., Walport M.J., Winfield J.B., Parker C.J., Fuller C.R., Taylor R.P., Myones B.L., and Lachmann P.J. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J. Immunol. 135 (1985) 2005-2014
26. Mitchell J.A., Sim R.B., and Sim E. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism. Clin. exp. Immunol. 78 (1989) 354-358
27. Dlugovitzky D., Luchesi S., Torres-Morales A., Ruiz-Silva J., Canosa B., Valentini E., and Bottasso O. Circulating immune complexes in patients with advanced tuberculosis and their association with autoantibodies and reduced CD4+ lymphocytes. Braz. J. Med. Biol. Res. 28 (1995) 331-335
28. Palaci M., Dietze R., Hadad D.J., Ribeiro F.K., Peres R.L., Vinhas S.A., Maciel E.L., do Valle Dettoni V., Horter L., Boom W.H., Johnson J.L., and Eisenach K.D. Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis. J. Clin. Microbiol. 45 (2007) 4064-4066
29. Toman K. Toman's Tuberculosis. Case Detection, Treatment and Monitoring. Questions and Answers (2004), World Health Organization, Geneva
30. Gopi P.G., Chandrasekaran V., Subramani R., Santha T., Thomas A., Selvakumar N., and Narayanan P.R. Association of conversion and cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen. Indian J. Med. Res. 123 (2006) 807-814
31. Reinagel M.L., Gezen M., Ferguson P.J., Kuhn S., Martin E.N., and Taylor R.P. The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis. Blood. 89 (1997) 1068-1077
32. Cohen J.H., Geffriaud C., Caudwell V., and Kazatchkine M.D. Genetic analysis of CR1 (the C3b complement receptor, CD35) expression on erythrocytes of HIV-infected individuals. AIDS 3 (1989) 397-399
33. Kumar A., Kumar A., Sinha S., Khandekar P.S., Banerjee K., and Srivastava L.M. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon. Immunol. Cell Biol. 73 (1995) 457-462